Shantha Biotech plans to raise US$ 25 millionIllustrative image – not actual.

Shantha Biotechnics has plans to reportedly, raise US$ 25 million (approx. Rs.120 crore) by selling a stake to new investors.

 

According to Managing Director and company founder, Mr Varaprasad Reddy, the funds would be used to build a US Drug Administration-approved plant to make new products.

 

In September 2000, Morgan Stanley and the State Bank of India paid $11 million for a combined 6.9 per cent holding.

 

Shantha Biotechnics was founded in 1992 with US$ 7 lakh (approx. Rs.336 lakh) in seed money, half from Reddy and 3 US-based Indian partners and the remainder from the foreign minister of Oman and associates.

← All latest storiesBack to top →